Sistema de Información Esencial en Terapéutica y Salud


Última actualización: 18/9/2019
SIETES contiene 92806 citas

 1 a 20 de 51 siguiente >>
Presentar resultados
Seleccionar todas
1.Enlace a cita original Cita con resumen
Avorn J. The psychology of clinical decision making — Implications for medication use. N Engl J Med 2018;378:22 de febrero. [Ref.ID 102556]
2. Cita con resumen
Pacurariu AC, Coloma PM, Gross-Martirosyan L, Sturkenboom MC, Straus SM. Decision making in drug safety — A literature review of criteria used to prioritize newly detected safety issues. Pharmacoepidemiol Drug Saf 2017;26:327-34. [Ref.ID 101955]
3. Cita con resumen
Bright TJ, Kimani PK, Bullock I, Clutton-Brock T, Davies RP, Gale M, Lam J, Lockey A, Stallard N, and on behalf of the Electronic Advanced Life Support Collaborators. Effect of clinical decision-support systems: a systematic review. Ann Intern Med 2012;157:29-43. [Ref.ID 93385]
Krumholz HM, Ross JS. A model for dissemination and independent analysis of industry data. JAMA 2011;306:1593-4. [Ref.ID 91545]
5. Cita con resumen
Mullan RJ, Montori VM, Shah ND, Christianson TJH, Bryant SC, Guyatt GH, Perestelo-Perez LI, Stroebel RJ, Yawn BP, Yapuncich V, Breslin MA, Pencille L, Smith SA. The diabetes mellitus medication choice decision aid. A randomized trial. Arch Intern Med 2009;169:1560-8. [Ref.ID 86843]
6. Cita con resumen
Aronson JK, Price D, Ferner RE. A strategy for regulatory action when new adverse effects of a licensed product emerge. Drug Saf 2009;32:91-8. [Ref.ID 85478]
7.Tiene citas relacionadas Cita con resumen
Schneeweiss S, Avorn J. Antipsychotic agents and sudden cardiac death - How should we manage the risk?. N Engl J Med 2009;360:294-6. [Ref.ID 84997]
8. Cita con resumen
Weymiller AJ, Montori VM, Jones LA, Gafni A, Guyatt GH, Bryant SC, Christianson TJH, Mullan RJ, Smith SA. Helping patients with type 2 diabetes mellitus make treatment decisions. Statin choice randomized trial. Arch Intern Med 2007;167:1076-82. [Ref.ID 80229]
Halvorsen PA, Kristiansen IS. Decisions on drug therapies by numbers needed to treat. A randomized trial. Arch Intern Med 2005;165:1140-6. [Ref.ID 73957]
10. Cita con resumen
Jovell AJ. Ética de lad decisiones sanitarias. Med Clin (Barc) 2005;124:580-2. [Ref.ID 73525]
11.Tiene citas relacionadas
Bradley CP. Commentary: Can we avoid bias?. BMJ 2005;330:784. [Ref.ID 73295]
12.Tiene citas relacionadas
Klein JG. Five pitfalls in decisions about diagnosis and prescribing. BMJ 2005;330:781-4. [Ref.ID 73294]
13. Cita con resumen
Rosen S, Sanne I, Collier A, Simon JL. Hard choices: rationing antiretroviral therapy for HIV/AIDS in Africa. Lancet 2005;365:354-6. [Ref.ID 72588]
Boissel JP, Amsallem E, Cucherat M, Nony P, Haugh MC. Bridging the gap between therapeutic research results and physician prescribing decisions: knowledge transfer, a prerequisite to knowledge translation. Eur J Clin Pharmacol 2004;60:609-16. [Ref.ID 72255]
Paul C. The relentless therapeutic imperative. BMJ 2004;329:1457-9. [Ref.ID 72247]
Anónimo. Improving pharmacovigilance practice beyond spontaneous reporting. WHO Drug Information 2004;18:203-6. [Ref.ID 71948]
17. Cita con resumen
Ariza-Ariza R, Hernández-Cruz B, Navarro-Sarabia F. Rofecoxib frente a antiinflamatorios no esteroideos en el tratamiento de la artrosis: análisis coste-efectividad para España. Rev Clin Esp 2004;204:457-65. [Ref.ID 71566]
18.Tiene citas relacionadas
Corbett N, Deschaumbault D, with the support of Nancy Santesso. Commentary: Patients' view. BMJ 2004;329:40. [Ref.ID 70624]
19.Tiene citas relacionadas
Cranney A. Commentary: Decision aids in clinical practice. BMJ 2004;329:39-40. [Ref.ID 70623]
20.Tiene citas relacionadas
Cantillon P. Commentary: Is evidence based patient choice feasible?. BMJ 2004;329:39. [Ref.ID 70622]
Seleccionar todas
 1 a 20 de 51 siguiente >>